Tag: Belluscura

LONDON and PLANO, Texas – Belluscura has announced a possible acquisition and has made a change to its executive leadership.  Belluscura has reached an agreement with TMT Acquisitions, a London-based acquisition vehicle in the technology, media and telecommunications sector, on the key terms of a possible share-for-share offer for the company, in a deal that would be valued at EUR 6 million. Belluscura will use the deal, which includes a $100,000 break-up fee, to help grow its portable...

LONDON and PLANO, Texas – Belluscura has announced a possible acquisition and has made a change to its executive leadership.  Belluscura has reached an agreement with TMT Acquisitions, a London-based acquisition vehicle in the technology, media and telecommunications sector, on the key terms of a possible share-for-share offer for the company, in a deal that would be valued at EUR 6 million. Belluscura will use the deal, which includes a $100,000 break-up fee, to help grow its portable...

LONDON and PLANO, Texas – Belluscura has received approval from the Hong Kong Department of Health – Medical Device Division to distribute its X-PLOR portable oxygen concentrator. The company has already received its first purchase order from a Hong Kong distributor. "We are very excited to receive the approval and begin sales in Hong Kong,” said Bob Rauker, CEO of Belluscura. “I am very pleased with our operations, quality control and sales teams receiving approval ahead...

LONDON and PLANO, Texas – Belluscura has entered into an exclusive licensing, marketing and distribution agreement with China-based InnoMax Medical Technology to manufacture and distribute Belluscura's X-PLOR portable oxygen concentrator in China, Hong Kong, Macau and Singapore (the Territories). The agreement will also include the DISCOV-R, the Belluscura's next generation, ambulatory dual flow portable oxygen concentrator, when registration is received in the Territories for both...

LONDON and PLANO, Texas – Belluscura has received purchase orders for more than 6,500 of its DISCOV-R portable oxygen concentrators, representing about $15 million of potential revenue. The company plans to begin initial production of the POC by the end of this quarter. "We are very excited about the overwhelming interest in the DISCOV-R by online retail sellers and other medical equipment providers,” said Bob Fary, senior vice president of global sales. “Following the pre-market...

LONDON AND PLANO, Texas – Belluscura has signed a distribution agreement with McKesson Medical-Surgical to distribute its X-PLOR portable oxygen concentrator. “We continue to expand the distribution of the X-PLOR throughout the U.S. and this exciting agreement will extend our reach to patients seeking access to best-in-class devices," said Robert Fary, senior vice president of global sales, Belluscura. In April, Belluscura secured a marketing agreement with the popular website GoodRx...

LONDON and PLANO, Texas – Belluscura reported group revenue of $1.54 million for the year ended Dec. 31, 2022, compared to $420,000 the previous year. It reported adjusted losses from operations of $6.2 million vs. $4.2 million, and net cash of $2.04 million. Among its highlights for the year: built significant U.S. distribution and commenced international roll-out; established manufacturing facilities in both the U.S. and China; launched the next generation X-PLOR, with initial new standing...

LONDON, and PLANO, Texas – Belluscura has raised gross proceeds of £3 million (approximately £2.7 million net of expenses) through the issue of 12 million new ordinary shares at the issue price of 25 pence per share. The company has also announced a retail offer to raise up to £0.5 million (before expenses) through the issue of new ordinary shares of 1 penny each in the share capital of the company. Under the retail offer, up to two million new ordinary shares will be made...

LONDON, and PLANO, Texas – Belluscura has raised gross proceeds of £3 million (approximately £2.7 million net of expenses) through the issue of 12 million new ordinary shares at the issue price of 25 pence per share. The company has also announced a retail offer to raise up to £0.5 million (before expenses) through the issue of new ordinary shares of 1 penny each in the share capital of the company. Under the retail offer, up to two million new ordinary shares will be made...

LONDON and PLANO, Texas – Belluscura has secured a marketing agreement with the popular website GoodRx to increase direct-to-consumer sales of its X-PLOR portable oxygen concentrator.  Santa Monica, Calif.-based GoodRx operates www.goodrx.com and a mobile app that allow users to compare drug prices and get free coupons that they can use at the pharmacy. The company, which also operates a telehealth platform, estimates it has helped Americans save $35 billion on health care and prescription...